Association of Genetic Variants in miR-217 Gene with Risk of Coronary Artery Disease: A Case–Control Study

References

• Hata J, Kiyohara Y. Epidemiology of stroke and coronary artery disease in Asia. Circ J. 2013;77(8):1923–1932. doi:10.1253/circj.CJ-13-0786
   PubMed Web of Science ®Google Scholar
• Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
   Web of Science ®Google Scholar
• Wong MC, Zhang DX, Wang HH. Rapid emergence of atherosclerosis in Asia: a systematic review of coronary atherosclerotic heart disease epidemiology and implications for prevention and control strategies. Curr Opin Lipidol. 2015;26(4):257–269. doi:10.1097/MOL.0000000000000191
   PubMed Web of Science ®Google Scholar
• Widmer RJ, Lerman LO, Lerman A. MicroRNAs: small molecule, big potential for coronary artery disease. Eur Heart J. 2016;37(22):1750–1752. doi:10.1093/eurheartj/ehw067
   Web of Science ®Google Scholar
• Ghafouri-Fard S, Gholipour M, Taheri M. Role of MicroRNAs in the pathogenesis of coronary artery disease. Front Cardiovasc Med. 2021;8:632392. doi:10.3389/fcvm.2021.632392
   PubMed Web of Science ®Google Scholar
• de Yebenes VG, Briones AM, Martos-Folgado I, et al. Aging-associated miR-217 aggravates atherosclerosis and promotes cardiovascular dysfunction. Arterioscler Thromb Vasc Biol. 2020;40(10):2408–2424. doi:10.1161/ATVBAHA.120.314333
   PubMed Web of Science ®Google Scholar
• Sun Z, Shen Y, Lu L, et al. Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease. Circ J. 2014;78(5):1191–1196. doi:10.1253/circj.CJ-13-1143
   Web of Science ®Google Scholar
• Li Y, Fei L, Wang J, Niu Q. Inhibition of miR-217 protects against myocardial ischemia-reperfusion injury through inactivating NF-kappaB and MAPK pathways. Cardiovasc Eng Technol. 2020;11(2):219–227. doi:10.1007/s13239-019-00452-z
   Web of Science ®Google Scholar
• Li J, Zhang Y, Guo X, Wu Y, Huang R, Han X. Circulating level of monocyte chemoattractant protein-1 and risk of coronary artery disease: a case-control and Mendelian randomization study. Pharmgenomics Pers Med. 2021;14:553–559.
   Web of Science ®Google Scholar
• Barrett JC. Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc. 2009;2009(10):pdbip71. doi:10.1101/pdb.ip71
   Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603.
   PubMed Web of Science ®Google Scholar
• Manfrini O, Yoon J, van der Schaar M, et al. Sex differences in modifiable risk factors and severity of coronary artery disease. J Am Heart Assoc. 2020;9(19):e017235. doi:10.1161/JAHA.120.017235
   Web of Science ®Google Scholar
• Lonnebakken MT. Cardiometabolic risk factors and coronary artery disease in women. J Womens Health (Larchmt). 2020;29(12):1489–1490. doi:10.1089/jwh.2020.8755
   Web of Science ®Google Scholar
• Sanlialp M, Dodurga Y, Uludag B, et al. Peripheral blood mononuclear cell microRNAs in coronary artery disease. J Cell Biochem. 2020;121(4):3005–3009. doi:10.1002/jcb.29557
   PubMed Web of Science ®Google Scholar
• Zhang X, Cai H, Zhu M, Qian Y, Lin S, Li X. Circulating microRNAs as biomarkers for severe coronary artery disease. Medicine (Baltimore). 2020;99(17):e19971. doi:10.1097/MD.0000000000019971
   PubMed Web of Science ®Google Scholar
• Wang -S-S, Wu L-J, Li -J-J-H, Xiao H-B, He Y, Yan Y-X. A meta-analysis of dysregulated miRNAs in coronary heart disease. Life Sci. 2018;215:170–181. doi:10.1016/j.lfs.2018.11.016
   Web of Science ®Google Scholar
• Dai H, Wang J, Shi Z, Ji X, Huang Y, Zhou R. Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100(10):e24966. doi:10.1097/MD.0000000000024966
   Web of Science ®Google Scholar
• Qiu X, Wang J, Shi Z, Ji X, Huang Y, Dai H. Predictive value of miRNA-126 on in-stent restenosis in patients with coronary heart disease: a protocol for meta-analysis and bioinformatics analysis. Medicine (Baltimore). 2021;100(22):e25887. doi:10.1097/MD.0000000000025887
   Web of Science ®Google Scholar
• Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis. 2010;31(10):1726–1733. doi:10.1093/carcin/bgq160
   PubMed Web of Science ®Google Scholar
• Deng S, Zhu S, Wang B, et al. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Cancer Lett. 2014;355(2):184–191. doi:10.1016/j.canlet.2014.08.007
   PubMed Web of Science ®Google Scholar
• Nishioka C, Ikezoe T, Yang J, Nobumoto A, Tsuda M, Yokoyama A. Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors. Cancer Sci. 2014;105(3):297–307. doi:10.1111/cas.12339
   PubMed Web of Science ®Google Scholar
• Popov A, Szabo A, Mandys V. Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer. BMC Cancer. 2015;15:774. doi:10.1186/s12885-015-1785-9
   PubMed Web of Science ®Google Scholar
• Xi S, Inchauste S, Guo H, et al. Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis. Oncogene. 2015;34(44):5548–5559. doi:10.1038/onc.2015.10
   PubMed Web of Science ®Google Scholar
• Menghini R, Casagrande V, Cardellini M, et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation. 2009;120(15):1524–1532. doi:10.1161/CIRCULATIONAHA.109.864629
   PubMed Web of Science ®Google Scholar
• Borghini A, Andreassi MG. Genetic polymorphisms offer insight into the causal role of microRNA in coronary artery disease. Atherosclerosis. 2018;269:63–70. doi:10.1016/j.atherosclerosis.2017.12.022
   PubMed Web of Science ®Google Scholar
• Joehanes R, Zhang X, Huan T, et al. Integrated genome-wide analysis of expression quantitative trait loci aids interpretation of genomic association studies. Genome Biol. 2017;18(1):16. doi:10.1186/s13059-016-1142-6
   PubMed Web of Science ®Google Scholar
• Kaudewitz D, Skroblin P, Bender LH, et al. Association of MicroRNAs and YRNAs with platelet function. Circ Res. 2016;118(3):420–432. doi:10.1161/CIRCRESAHA.114.305663
   PubMed Web of Science ®Google Scholar
• Ghanbari M, Franco OH, de Looper HW, Hofman A, Erkeland SJ, Dehghan A. Genetic variations in MicroRNA-binding sites affect MicroRNA-mediated regulation of several genes associated with cardio-metabolic phenotypes. Circ Cardiovasc Genet. 2015;8(3):473–486. doi:10.1161/CIRCGENETICS.114.000968
   Google Scholar
• Li L, He M, Zhou L, et al. A solute carrier family 22 member 3 variant rs3088442 G–>A associated with coronary heart disease inhibits lipopolysaccharide-induced inflammatory response. J Biol Chem. 2015;290(9):5328–5340. doi:10.1074/jbc.M114.584953
   Web of Science ®Google Scholar
• Miller CL, Haas U, Diaz R, et al. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet. 2014;10(3):e1004263. doi:10.1371/journal.pgen.1004263
   PubMed Web of Science ®Google Scholar
• Glinsky GV. An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle. 2008;7(16):2570–2583. doi:10.4161/cc.7.16.6524
   PubMed Web of Science ®Google Scholar
• Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790–1797. doi:10.1101/gr.137323.112
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Databaseissue):D930–934. doi:10.1093/nar/gkr917
   Web of Science ®Google Scholar